WV.gov
Agency Header

Preferred Drug List 

The Preferred Drug List is a medication list recommended to the Bureau for Medical Services by the Medicaid Pharmaceutical and Therapeutics (P & T) Committee and approved by the Secretary of the Department of Health and Human Resources, as authorized by West Virginia Code §9-5-15.  The drugs which are indicated as "preferred" have been selected for their clinical significance and overall efficiencies.

All Medicaid-covered drugs noted as "non-preferred" will continue to be available through the prior authorization process.  Some select preferred drugs may require prior authorization, as noted.  A three-day emergency supply of prior-authorized drugs can be dispensed by a pharmacy until authorization is completed.

Please note:  The PDL only addresses certain drug classes.  Some classes of drugs will not be reviewed for preferential agents because of no or limited cost savings.  Therefore, drugs which have historically been covered by Medicaid and are not listed on the Preferred Drug List will contiue to be covered.

New drugs introduced into the marketplace in therapeutic classes that have been reviewed will be considered non-preferred until the annual review of the particular therapeutic class.  Exceptions to this policy will be made for drugs which the FDA has given priority status.

BMS contracts with Magellan Medicaid Administration, Inc. (MMA) for assistance with PDL development and clinical support.  BMS is also a member of the Sovereign States Drug Consortium (SSDC), the only state administered multi-state supplemental rebate pool.   For more information about MMA or SSDC, please refer to their websites at, http://www.rxssdc.org respectively.

PDL Frequently Asked Questions


P & T Committee Mission Statement

The West Virginia Medicaid Pharmaceutical and Therapeutics Committee is committed to:

  • Objectively recommending drugs for inclusion on the WV Preferred Drug List (PDL) that are effective and cost efficient, while providing maximum safety;
  • Examine the scientific literature (found in labeling, drug compendia, and peer reviewed clinical literature) for sound clinical evidence that supports selecting specific drugs to be included on the PDL
  • Ensure that the PDL provides for medically approriate drug therapies for use in the general Medicaid population, allowing healthcare providers to care for the majority of their patients without a prior authorization request.

PREFERRED DRUG LISTS

 

  Effective Date  Posted Date  
  April 1, 2013  March 26, 2013  
  April 1, 2013   March 4, 2013  
  January 1, 2013   February 26, 2013  
  January 1, 2013   January 11, 2013  
  January 1, 2013   January 3, 2013  
  January 1, 2013  December 10, 2012   
  January 1, 2013    December 7, 2012  
  January 1, 2013  December 5, 2012  
  November 1, 2012  November 1, 2012  
  October 1, 2012   October 1, 2012  
  October 1, 2012  September 26, 2012  
  October 1, 2012   September 7, 2012   
  August 17, 2012  September 26, 2012
  August 17, 2012  September 6, 2012
  July 1, 2012  June 27, 2012
  July 1, 2012  June 6, 2012
  June 11, 2012  June 7, 2012
  May 25, 2012  May 29, 2012
  April 12, 2012  April 17, 2012
  April 1, 2012  March 2, 2012
  January 1, 2012  February 6, 2012
  January 1, 2012  December 2, 2011
  October 1, 2011  October 3, 2011
  October 1, 2011  September 2, 2011
  July 1, 2011  June 10, 2011
  April 1, 2011 Cough/Cold NDC List (update)  April 1, 2011
  April 1, 2011  March 25, 2011
  April 1, 2011  March 11, 2011  
  April 1, 2011  March 4, 2011 
  January 1, 2011  February 25, 2011  
  January 1, 2011  December 29, 2010  
  January 1, 2011  December 1, 2010  
  October 1, 2010  October 22, 2010  
  October 1, 2010  September 1, 2010  
  August 10, 2010  August 10, 2010  
  August 1, 2010  July 30, 2010  
  August 1, 2010 Cough/Cold NDC List  July 30, 2010    
  July 1, 2010  June 1, 2010  
  April 1, 2010  May 5, 2010  
  April 1, 2010  April 16, 2010  
  April 1, 2010  March 29, 2010  
  April 1, 2010  March 10, 2010  
  January 1, 2010 Vitamin D NDC List  December 2, 2009    
  January 1, 2010  December 2, 2009  
  October 1, 2009  September 25, 2009  
  July 1, 2009  June 5, 2009  
  July 1, 2009 Cough/Cold NDC List  June 5, 2009    
  July 1, 2009 Prenatal Vitamin NDC List  June 5, 2009    
  June 1, 2009  June 5, 2009  
  April 1, 2009  March 5, 2009  
  January 1, 2009  November 26, 2008  
  November 3, 2008  October 20, 2008  
  September 2, 2008  August 29, 2008  
  August 11, 2008  August 8, 2009  (Criteria Changes)  
  July 1, 2008  June 16, 2008  
  April 1, 2008  April 7, 2008  (Criteria Changes)  
  April 1, 2008  March 28, 2008  (Criteria Changes)  
  April 1, 2008  March 4, 2008  
  October 1, 2007  November 13, 2007  (Drug List)  
  October 1, 2007  October 26, 2007  (Drug List)  
  October 1, 2007  October 2, 2007  (Criteria Changes)  
  October 1, 2007  October 1, 2007  (Criteria Changes)  
  October 1, 2007  September 18, 2007  (Drug List)  
  October 1, 2007  September 12, 2007  
  July 9, 2007  August 7, 2007  (Criteria Changes)  
  July 9, 2007  June 25, 2007  (Drug List)  
  April 2, 2007  June 13, 2007  (Drug List)  
  April 2, 2007  March 15, 2007  
  October 2, 2006  March 16, 2007  (Criteria Change)  
  October 2, 2006  January 19, 2007  (Drug List)  
  October 2, 2006  November 20, 2006  (Drug List)  
  October 2, 2006  October 27, 2006  (Criteria Change)   
  October 2, 2006  October 2, 2006  
  April 1, 2006  April 1, 2006  
  October 3, 2005  November 22, 2005  
  October 3, 2005  November 10, 2005  
  July 1, 2005  July 6, 2005  
  July 1, 2005  June 29, 2005  
  July 1, 2005  June 6, 2005  
  April 1, 2004  Phase VIII Tabled  
  April 1, 2004  Phase VIII DUR  
  November 1, 2003  October 29, 2003  
  November 1, 2003  Phase VII  
  August 15, 2003  Phase VI  
  May 1, 2003  Phase V  
  April 9, 2003  Phase IVa  
  April 9, 2003  April 7, 2003  
  March 5, 2003  Phase III  
  February 1, 2003  Phase IV  
  January 13, 2003  Phase I  
  January 7, 2003  March 31, 2003  
  December 1, 2002  Phase II